Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease

被引:1
|
作者
Janczewska, I [1 ]
Sagar, M
Sjöstedt, S
Hammarlund, B
Iwarzon, M
Seensalu, R
机构
[1] Huddinge Univ Hosp, Dept Gastroenterol & Hepatol, S-14186 Huddinge, Sweden
[2] St Gorans Hosp, Dept Med, Stockholm, Sweden
关键词
gastroesophageal reflux; 24-h intraesophageal intragastric acidity;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Lansoprazole (LAN) and omeprazole (OME) heal esophagitis effectively and to similar extents, but LAN has a faster effect on the relief of symptoms of gastroesophageal reflux. However, no strict comparison of the two proton pump inhibitors' effect on acid reflux and gastric acidity has been published. The aim of this study was to compare the effects of LAN and OME on gastroesophageal reflux with simultaneous measurements of gastric acidity in patients with established gastroesophageal reflux disease (GERD) and esophagitis. Methods: Fourteen patients with endoscopically verified erosive esophagitis and with a pretreatment esophageal 24-h pH measurement showing acid reflux to the esophagus participated in the study. This was a double-blind, randomized study with crossover design. Before (day 0) and on the last day (day 5) of each treatment period with encapsulated 30 mg LAN or 20 mg OME daily, 24-h intraesophageal and intragastric acidity were measured with antimony electrodes connected to an ambulatory pH recording system. Results: Ten of 14 patients completed the study. There were no differences in intragastric or intraesophageal acidity or the number of reflux episodes on day 0 between the two treatments. Both LAN and OME treatments increased the median and nocturnal intragastric pH and decreased the 24-h area under the time curve for intragastric acidity significantly and to about the same extent (79% and 69% acid inhibition by LAN and OME, respectively) (NS). However, the percentage of time with pH below 4 in the esophagus was significantly less during LAN treatment (1.92% +/- 2.29; mean +/- standard deviation) than during OME treatment (4.76% +/- 2.88%) on day 5 (P = 0.002). There were also significantly fewer reflux episodes >5 min during treatment with LAN (1.00 +/- 1.33) than with OME (2.90 +/- 2.42) at the end of the treatment period (P = 0.031). Conclusions: In this study lansoprazole and omeprazole had a comparable effect on gastric acidity in patients with established GERD with esophagitis. However, 30 mg lansoprazole daily reduced the acidity in the oesophagus and the number of refluxes more effectively than 20 mg omeprazole daily. This might indicate that proton pump inhibitors affect the esophageal clearance and/or influence the lower esophageal sphincter differently.
引用
收藏
页码:1239 / 1243
页数:5
相关论文
共 50 条
  • [21] Pharmacokinetics and pharmacodynamics of lansoprazole in children with gastroesophageal reflux disease
    Gremse, D
    Winter, H
    Tolia, V
    Gunasekaran, T
    Pan, WJ
    Karol, M
    Chiu, YL
    Pilmer, B
    Book, L
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 35 : S319 - S326
  • [22] Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children
    Tolia, V
    Fitzgerald, J
    Hassall, E
    Huang, BD
    Pilmer, B
    Kane, R
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 35 : S300 - S307
  • [23] The effect of baclofen on acid reflux and reflux mechanisms in patients with gastroesophageal reflux disease
    Herwaarden, MA
    Samsom, M
    Rydholm, H
    Smout, AAJP
    GASTROENTEROLOGY, 2001, 120 (05) : A433 - A433
  • [24] Efficacy and cost effectiveness of lansoprazole versus omeprazole in maintenance treatment of symptomatic gastroesophageal reflux disease
    Vivian, E
    Morreale, A
    Boyce, E
    Lowry, K
    Ereso, O
    Hlavin, P
    AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (07): : 881 - 886
  • [25] THERAPEUTIC MONITORING OF OMEPRAZOLE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
    HENDEL, L
    HAGE, E
    HENDEL, J
    AGGESTRUP, S
    HENDEL, J
    GASTROENTEROLOGY, 1993, 104 (04) : A99 - A99
  • [26] OMEPRAZOLE - DEFINING ITS ROLE IN GASTROESOPHAGEAL REFLUX DISEASE
    BERARDI, RR
    DUNNKUCHARSKI, VA
    HOSPITAL FORMULARY, 1995, 30 (04): : 216 - 225
  • [27] MORNING OR EVENING DOSAGE OF OMEPRAZOLE FOR GASTROESOPHAGEAL REFLUX DISEASE
    HENDEL, J
    HENDEL, L
    AGGESTRUP, S
    GASTROENTEROLOGY, 1993, 104 (04) : A98 - A98
  • [28] Gastroesophageal reflux disease in bronchial asthma and the response to omeprazole
    Gopal, B
    Singhal, P
    Gaur, SN
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2005, 23 (01): : 29 - 34
  • [29] OMEPRAZOLE AS A DIAGNOSTIC-TOOL IN GASTROESOPHAGEAL REFLUX DISEASE
    KUIPERS, EJ
    KLINKENBERGKNOL, EC
    JANSEN, EH
    TUYNMAN, HARE
    FESTEN, HPM
    SCHRIJVER, M
    MEUWISSEN, SGM
    GASTROENTEROLOGY, 1995, 108 (04) : A137 - A137
  • [30] Comparative role of omeprazole in the treatment of gastroesophageal reflux disease
    Skoutakis, VA
    Joe, RH
    Hara, DS
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (12) : 1252 - 1262